Primary |
Product Used For Unknown Indication |
35.1% |
Drug Use For Unknown Indication |
25.3% |
Anxiety |
8.4% |
Depression |
6.9% |
Insomnia |
3.4% |
Agitation |
2.6% |
Schizophrenia |
2.4% |
Psychotic Disorder |
2.2% |
Sedation |
2.0% |
Hypertension |
1.5% |
Convulsion |
1.5% |
Sleep Disorder |
1.4% |
Intentional Overdose |
1.3% |
Mania |
1.2% |
Pain |
1.0% |
Suicide Attempt |
1.0% |
Bipolar Disorder |
0.7% |
Diabetes Mellitus |
0.7% |
Drug Abuse |
0.7% |
Schizoaffective Disorder |
0.7% |
|
Suicide Attempt |
13.3% |
Tachycardia |
12.0% |
Completed Suicide |
9.6% |
Poisoning |
8.4% |
Somnolence |
6.9% |
Vomiting |
6.6% |
Sopor |
4.6% |
Toxicity To Various Agents |
4.4% |
Respiratory Arrest |
4.3% |
Death |
4.0% |
Syncope |
4.0% |
Unresponsive To Stimuli |
3.1% |
Tremor |
2.7% |
Cardio-respiratory Arrest |
2.6% |
Withdrawal Syndrome |
2.5% |
Overdose |
2.4% |
Sedation |
2.4% |
Product Substitution Issue |
2.3% |
Delirium |
2.0% |
Weight Increased |
1.9% |
|
Secondary |
Product Used For Unknown Indication |
39.0% |
Drug Use For Unknown Indication |
16.7% |
Depression |
9.4% |
Anxiety |
6.3% |
Hypertension |
2.9% |
Insomnia |
2.9% |
Pain |
2.8% |
Psychotic Disorder |
2.5% |
Agitation |
2.4% |
Drug Abuse |
2.1% |
Schizophrenia |
1.8% |
Bipolar Disorder |
1.6% |
Suicide Attempt |
1.5% |
Self Injurious Behaviour |
1.5% |
Status Epilepticus |
1.2% |
Sedation |
1.2% |
Dementia Alzheimer's Type |
1.1% |
Convulsion |
1.0% |
Diabetes Mellitus |
1.0% |
Sleep Disorder |
1.0% |
|
Completed Suicide |
19.8% |
Suicide Attempt |
14.0% |
Toxicity To Various Agents |
8.3% |
Somnolence |
5.6% |
Respiratory Arrest |
5.4% |
Death |
5.2% |
Vomiting |
4.9% |
Overdose |
3.8% |
Drug Toxicity |
3.3% |
Unresponsive To Stimuli |
3.3% |
Weight Increased |
3.0% |
Cardio-respiratory Arrest |
2.9% |
Poisoning |
2.9% |
Tachycardia |
2.9% |
Insomnia |
2.7% |
Sopor |
2.7% |
Vertigo |
2.5% |
Fall |
2.3% |
Suicidal Ideation |
2.3% |
Drug Abuse |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
26.6% |
Drug Use For Unknown Indication |
18.8% |
Pain |
6.7% |
Depression |
6.6% |
Anxiety |
6.3% |
Hypertension |
5.5% |
Prophylaxis |
3.6% |
Insomnia |
3.4% |
Nausea |
3.1% |
Schizophrenia |
2.5% |
Bipolar Disorder |
2.0% |
Rheumatoid Arthritis |
1.9% |
Gastrooesophageal Reflux Disease |
1.9% |
Sleep Disorder |
1.8% |
Multiple Myeloma |
1.7% |
Constipation |
1.7% |
Breast Cancer |
1.6% |
Non-small Cell Lung Cancer |
1.5% |
Diabetes Mellitus |
1.4% |
Osteoporosis |
1.4% |
|
Vomiting |
16.6% |
Weight Decreased |
8.3% |
Weight Increased |
8.1% |
Tremor |
5.1% |
Pulmonary Embolism |
4.9% |
Death |
4.7% |
Nausea |
4.6% |
Type 2 Diabetes Mellitus |
4.6% |
Urinary Tract Infection |
4.3% |
White Blood Cell Count Decreased |
3.8% |
Drug Ineffective |
3.8% |
Thrombocytopenia |
3.8% |
Pain |
3.7% |
Pneumonia |
3.6% |
Rash |
3.4% |
Pyrexia |
3.4% |
Syncope |
3.4% |
Somnolence |
3.3% |
Suicidal Ideation |
3.3% |
Vision Blurred |
3.2% |
|
Interacting |
Product Used For Unknown Indication |
29.1% |
Depression |
15.1% |
Drug Use For Unknown Indication |
15.0% |
Diabetes Mellitus |
7.8% |
Tachyarrhythmia |
3.8% |
Anaesthesia |
3.0% |
Anxiety |
3.0% |
Blood Cholesterol Increased |
2.1% |
Hypertension |
2.1% |
Restless Legs Syndrome |
2.1% |
Schizophrenia, Catatonic Type |
2.1% |
Suicide Attempt |
2.1% |
Dyslipidaemia |
1.9% |
High Density Lipoprotein Decreased |
1.8% |
Sedation |
1.8% |
Analgesic Therapy |
1.6% |
Insomnia |
1.5% |
Neck Pain |
1.5% |
Psychotic Disorder |
1.5% |
Back Pain |
1.1% |
|
Myocardial Infarction |
15.6% |
Drug Interaction |
13.3% |
Somnolence |
7.8% |
Syncope |
6.7% |
Tremor |
6.7% |
Gait Disturbance |
5.6% |
Suicide Attempt |
5.6% |
Visual Impairment |
5.6% |
Respiratory Depression |
4.4% |
Fall |
3.3% |
Hyperventilation |
3.3% |
Infectious Peritonitis |
3.3% |
Premature Labour |
3.3% |
Anxiety |
2.2% |
Disorientation |
2.2% |
Dizziness |
2.2% |
Enuresis |
2.2% |
Hallucination |
2.2% |
Miosis |
2.2% |
Nervousness |
2.2% |
|